SCHEMBL9308698

SCHEMBL9308698

CCCCc1nc(C)c(C(=O)OCC)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
HTT P42858 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 2/20 0.45
RECQL P46063 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 1/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
LMNA P02545 1/20 0.43
PDE4D Q08499 1/20 0.39
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
GPR84 Q9NQS5 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809049 0.90 ALDH1A1 (0.47) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL27346013 0.86 GPR84 (0.37) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL7309807 0.86 ALDH1A1 (0.44) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL9308574 0.85 ALDH1A1 (0.43) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL9206394 0.85 ALDH1A1 (0.61) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL7423269 0.85 ALDH1A1 (0.43) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL7303130 0.84 ALDH1A1 (0.42) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL3027865 0.83 ALDH1A1 (0.50) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL7268595 0.82 ALDH1A1 (0.41) ALDH1A1HTTHPGDKDM4ERECQL
SCHEMBL27296914 0.81 GPR84 (0.34) ALDH1A1HTTHPGDKDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed
EP-0434249-A2 Benzofuran derivatives GLAXO GROUP LIMITED (GB) 1991-06-26 EP disclosed